Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st

DUBLIN, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
July 22, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models

DUBLIN, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
July 08, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator

DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
July 03, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference

DUBLIN, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
June 20, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)

DUBLIN, Calif., June 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
June 14, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology Association

DUBLIN, Calif., June 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
May 29, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at Jefferies Global Healthcare Conference

DUBLIN, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
May 14, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at UBS Global Healthcare Conference

DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
April 29, 2013 16:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Reports 2013 First Quarter Financial Results

Data reported at AACR on several preclinical and clinical programs Ends quarter with $137 million in cash & marketable securities First quarter royalty revenue increases 7.3% to $22.1...
April 23, 2013 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at Needham Healthcare Conference

DUBLIN, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right